Use of riboflavin for photoinactivation of pathogens in blood components

Author： Schuyler R.  

Publisher： Elsevier

ISSN： 1473-0502

Source： Transfusion and Apheresis Science, Vol.25, Iss.3, 2001-12, pp. : 189-190

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inactivation of infectious pathogens in labile blood components: meeting the challenge

By Corash L.  

Transfusion Clinique et Biologique, Vol. 8, Iss. 3, 2001-06 ,pp. : 138-145

Elsevier

Access to resources Recommend Favorite

Helinx technology for inactivation of infectious pathogens and leukocytes in labile blood components: from theory to clinical application

By Corash L.  

Transfusion and Apheresis Science, Vol. 25, Iss. 3, 2001-12 ,pp. : 179-181

Elsevier

Access to resources Recommend Favorite

Bacterial contamination of blood components

By Seghatchian J.  

Transfusion and Apheresis Science, Vol. 25, Iss. 2, 2001-10 ,pp. : 147-150

Elsevier

Access to resources Recommend Favorite

Leukodepleted Blood Components: Definition of a Standard

By Andreu G.   Masse M.   Royer S.D.   Tardivel R.  

Transfusion and Apheresis Science, Vol. 19, Iss. 4, 1998-12 ,pp. : 381-383

Elsevier

Access to resources Recommend Favorite

Should Hospitals Collect Blood Components?: No

By Popovsky M.A.  

Transfusion and Apheresis Science, Vol. 18, Iss. 4, 1997-12 ,pp. : 545-551

Elsevier

Access to resources Recommend Favorite